Literature DB >> 17457101

The GBV-C envelope glycoprotein E2 does not interact specifically with CD81.

Thomas M Kaufman1, James H McLinden, Jinhua Xiang, Alfred M Engel, Jack T Stapleton.   

Abstract

The addition of GB virus C (GBV-C) E2 protein to cells inhibits HIV replication in vitro, presumably triggered by interactions with a specific cellular receptor. Indirect evidence suggests that CD81 is the GBV-C E2 cellular receptor. We found that E2 binding to cells was not dependent upon human CD81, and that soluble CD81 did not compete with GBV-C E2 for cell binding. GBV-C E2 protein thus does not appear to interact with CD81.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17457101     DOI: 10.1097/QAD.0b013e3280f77412

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  5 in total

Review 1.  Role of GB virus C in modulating HIV disease.

Authors:  Carolynne Schwarze-Zander; Jason T Blackard; Juergen K Rockstroh
Journal:  Expert Rev Anti Infect Ther       Date:  2012-05       Impact factor: 5.091

2.  GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates.

Authors:  Emma L Mohr; Jinhua Xiang; James H McLinden; Thomas M Kaufman; Qing Chang; David C Montefiori; Donna Klinzman; Jack T Stapleton
Journal:  J Immunol       Date:  2010-09-08       Impact factor: 5.422

Review 3.  Human Pegivirus Type 1: A Common Human Virus That Is Beneficial in Immune-Mediated Disease?

Authors:  Jack T Stapleton
Journal:  Front Immunol       Date:  2022-05-30       Impact factor: 8.786

Review 4.  GB virus type C interactions with HIV: the role of envelope glycoproteins.

Authors:  Emma L Mohr; Jack T Stapleton
Journal:  J Viral Hepat       Date:  2009-09-15       Impact factor: 3.728

5.  RNA interference effectively degrades mRNA and inhibits protein expression of GBV-C E2 gene in Huh7 cells.

Authors:  Ming-Mei Cao; Gang Li; Hao Ren; Wei Pan; Ping Zhao; Zhong-Tian Qi
Journal:  Virus Genes       Date:  2009-10-03       Impact factor: 2.332

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.